167 related articles for article (PubMed ID: 9001725)
21. Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model.
Mandal S; Mandal SD; Chuttani K; Sawant KK; Subudhi BB
Drug Dev Ind Pharm; 2016 Aug; 42(8):1340-50. PubMed ID: 26710671
[TBL] [Abstract][Full Text] [Related]
22. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
[TBL] [Abstract][Full Text] [Related]
23. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
25. Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent.
Filipov NM; Norwood AB; Sistrunk SC
Neuroreport; 2009 May; 20(7):713-7. PubMed ID: 19349914
[TBL] [Abstract][Full Text] [Related]
26. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
Cosi C; Marien M
Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
[TBL] [Abstract][Full Text] [Related]
27. Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Aguiar AS; Tristão FS; Amar M; Chevarin C; Lanfumey L; Mongeau R; Corti O; Prediger RD; Raisman-Vozari R
Neurotox Res; 2013 Aug; 24(2):280-7. PubMed ID: 23588969
[TBL] [Abstract][Full Text] [Related]
28. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
Tanji H; Araki T; Nagasawa H; Itoyama Y
Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
Sundström E; Jonsson G
Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
[TBL] [Abstract][Full Text] [Related]
30. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
31. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
32. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function.
Robinson S; Freeman P; Moore C; Touchon JC; Krentz L; Meshul CK
Exp Neurol; 2003 Mar; 180(1):74-87. PubMed ID: 12668150
[TBL] [Abstract][Full Text] [Related]
33. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
34. Age-related effects of MPTP on norepinephrine concentrations of various areas of rat brains.
Tsai HW; Tsai YF
Chin J Physiol; 1992; 35(4):349-56. PubMed ID: 1364058
[TBL] [Abstract][Full Text] [Related]
35. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
36. Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Battaglia G; Gesi M; Lenzi P; Busceti CL; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2002 Jun; 965():254-66. PubMed ID: 12105101
[TBL] [Abstract][Full Text] [Related]
37. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
38. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
39. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice.
Dluzen DE; Story GM; Xu K; Kucera J; Walro JM
Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice.
Kitamura Y; Itano Y; Kubo T; Nomura Y
J Neuroimmunol; 1994 Mar; 50(2):221-4. PubMed ID: 7509816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
